@article{Breccia_Colafigli_Quattrocchi_abruzzese_alimena_2016, title={Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia}, volume={8}, url={https://www.mjhid.org/mjhid/article/view/2016.016}, DOI={10.4084/mjhid.2016.016}, abstractNote={<p>Ponatinib a third generation tyrosine kinase inhibitor, has been approved for all phases of disease in CML. In advanced phase, has been confirmed with a good efficacy in all type of resistance, including T315I kinase domain mutation. We here report activity of the drug in advanced phase with extramedullary localization.</p>}, journal={Mediterranean Journal of Hematology and Infectious Diseases}, author={Breccia, Massimo and Colafigli, Gioia and Quattrocchi, Luisa and abruzzese, elisabetta and alimena, giuliana}, year={2016}, month={Feb.}, pages={e2016016} }